Topiramate vs placebo or no treatment
Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain
Topiramate showed no clear difference in leaving the study early: for any reason compared with placebo or no treatment (low certainty).
1 finding from 1 review
- Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes onlyRR 1.09 [0.85, 1.41]2 studies · 132 participantsLow